![Anticoagulant Reversal Strategies in the Emergency Department Setting: Recommendations of a Multidisciplinary Expert Panel - ScienceDirect Anticoagulant Reversal Strategies in the Emergency Department Setting: Recommendations of a Multidisciplinary Expert Panel - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0196064419311813-gr1.jpg)
Anticoagulant Reversal Strategies in the Emergency Department Setting: Recommendations of a Multidisciplinary Expert Panel - ScienceDirect
![Mean anti-Xa activity concentration (+ standard deviation) of the index... | Download Scientific Diagram Mean anti-Xa activity concentration (+ standard deviation) of the index... | Download Scientific Diagram](https://www.researchgate.net/profile/Mirjam-Rommers/publication/6994424/figure/tbl2/AS:669613486510095@1536659704870/figure-tbl2_Q320.jpg)
Mean anti-Xa activity concentration (+ standard deviation) of the index... | Download Scientific Diagram
![Mean anti-Xa activity concentration (+ standard deviation) of the index... | Download Scientific Diagram Mean anti-Xa activity concentration (+ standard deviation) of the index... | Download Scientific Diagram](https://www.researchgate.net/publication/6994424/figure/fig1/AS:195333146583042@1423582459532/Mean-anti-Xa-activity-concentration-standard-deviation-of-the-index-group-and-the.png)
Mean anti-Xa activity concentration (+ standard deviation) of the index... | Download Scientific Diagram
![Frontiers | Stable binding to phosphatidylserine-containing membranes requires conserved arginine residues in tandem C domains of blood coagulation factor VIII Frontiers | Stable binding to phosphatidylserine-containing membranes requires conserved arginine residues in tandem C domains of blood coagulation factor VIII](https://www.frontiersin.org/files/Articles/1040106/fmolb-09-1040106-HTML/image_m/fmolb-09-1040106-g001.jpg)
Frontiers | Stable binding to phosphatidylserine-containing membranes requires conserved arginine residues in tandem C domains of blood coagulation factor VIII
![Antifactor Xa levels at 0, 4, 12, and 24 hr after administration of 40... | Download Scientific Diagram Antifactor Xa levels at 0, 4, 12, and 24 hr after administration of 40... | Download Scientific Diagram](https://www.researchgate.net/publication/236043770/figure/fig1/AS:202601984466964@1425315485479/Antifactor-Xa-levels-at-0-4-12-and-24-hr-after-administration-of-40-mg-of-enoxaparin.png)
Antifactor Xa levels at 0, 4, 12, and 24 hr after administration of 40... | Download Scientific Diagram
![Prevalentie van correcte anti-Xa-bloedspiegels bij patiënten met verminderde nierfunctie op basis van dosisadvies conform richtlijn Nederlandse Federatie voor Nefrologie | NPFO Prevalentie van correcte anti-Xa-bloedspiegels bij patiënten met verminderde nierfunctie op basis van dosisadvies conform richtlijn Nederlandse Federatie voor Nefrologie | NPFO](https://www.npfo.nl/assets/styles/article_image/public/article/image/c27d3c40362c4a0f9981e4e116ec931a_a1610%20Figuur%201.jpg?itok=i0MtsRsl)
Prevalentie van correcte anti-Xa-bloedspiegels bij patiënten met verminderde nierfunctie op basis van dosisadvies conform richtlijn Nederlandse Federatie voor Nefrologie | NPFO
![Prevalentie van correcte anti-Xa-bloedspiegels bij patiënten met verminderde nierfunctie op basis van dosisadvies conform richtlijn Nederlandse Federatie voor Nefrologie | NPFO Prevalentie van correcte anti-Xa-bloedspiegels bij patiënten met verminderde nierfunctie op basis van dosisadvies conform richtlijn Nederlandse Federatie voor Nefrologie | NPFO](https://www.npfo.nl/assets/styles/article_image/public/article/image/c57850b96a8043239088be2a4b399704_a1610%20Tabel%201.jpg?itok=dN8BJJ02)
Prevalentie van correcte anti-Xa-bloedspiegels bij patiënten met verminderde nierfunctie op basis van dosisadvies conform richtlijn Nederlandse Federatie voor Nefrologie | NPFO
![Biomedicines | Free Full-Text | Pharmacotherapy in COVID 19: Potential Impact of Targeting the Complement System Biomedicines | Free Full-Text | Pharmacotherapy in COVID 19: Potential Impact of Targeting the Complement System](https://www.mdpi.com/biomedicines/biomedicines-09-00011/article_deploy/html/images/biomedicines-09-00011-g001.png)
Biomedicines | Free Full-Text | Pharmacotherapy in COVID 19: Potential Impact of Targeting the Complement System
![Mean anti-Xa activity concentration (+ standard deviation) of the index... | Download Scientific Diagram Mean anti-Xa activity concentration (+ standard deviation) of the index... | Download Scientific Diagram](https://www.researchgate.net/profile/Mirjam-Rommers/publication/6994424/figure/fig1/AS:195333146583042@1423582459532/Mean-anti-Xa-activity-concentration-standard-deviation-of-the-index-group-and-the_Q320.jpg)
Mean anti-Xa activity concentration (+ standard deviation) of the index... | Download Scientific Diagram
![Anti-Xa top- en dalspiegels bij therapeutisch gedoseerd nadroparine in patiënten met en zonder nierfunctiestoornissen of obesitas | NPFO Anti-Xa top- en dalspiegels bij therapeutisch gedoseerd nadroparine in patiënten met en zonder nierfunctiestoornissen of obesitas | NPFO](https://www.npfo.nl/assets/article/images/a1745_figuur%201.jpg)
Anti-Xa top- en dalspiegels bij therapeutisch gedoseerd nadroparine in patiënten met en zonder nierfunctiestoornissen of obesitas | NPFO
![Nonhemostatic Activities of Factor Xa: Are There Pleiotropic Effects of Anti-FXa Direct Oral Anticoagulants? - Styliani Papadaki, Alexandros D. Tselepis, 2019 Nonhemostatic Activities of Factor Xa: Are There Pleiotropic Effects of Anti-FXa Direct Oral Anticoagulants? - Styliani Papadaki, Alexandros D. Tselepis, 2019](https://journals.sagepub.com/cms/10.1177/0003319719840861/asset/images/large/10.1177_0003319719840861-fig2.jpeg)
Nonhemostatic Activities of Factor Xa: Are There Pleiotropic Effects of Anti-FXa Direct Oral Anticoagulants? - Styliani Papadaki, Alexandros D. Tselepis, 2019
![Epitope specificity of anti-FVIII antibodies during immune tolerance therapy with factor VIII preparation containing von Willebrand factor - Thrombosis Research Epitope specificity of anti-FVIII antibodies during immune tolerance therapy with factor VIII preparation containing von Willebrand factor - Thrombosis Research](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/1299505/8963772/gr1.gif)
Epitope specificity of anti-FVIII antibodies during immune tolerance therapy with factor VIII preparation containing von Willebrand factor - Thrombosis Research
![Labortests (1) Therapiekontrolle für Cumarin-Derivate Aufschluss über Funktionsleistung des extrinsischen Systems Thromboplastin-zeit [s] Verdünnung. - ppt herunterladen Labortests (1) Therapiekontrolle für Cumarin-Derivate Aufschluss über Funktionsleistung des extrinsischen Systems Thromboplastin-zeit [s] Verdünnung. - ppt herunterladen](https://slideplayer.org/slide/14537142/90/images/6/Labortests+%284%29+Anti-Faktor+Xa+Aktivit%C3%A4t.jpg)
Labortests (1) Therapiekontrolle für Cumarin-Derivate Aufschluss über Funktionsleistung des extrinsischen Systems Thromboplastin-zeit [s] Verdünnung. - ppt herunterladen
![Nonhemostatic Activities of Factor Xa: Are There Pleiotropic Effects of Anti-FXa Direct Oral Anticoagulants? - Styliani Papadaki, Alexandros D. Tselepis, 2019 Nonhemostatic Activities of Factor Xa: Are There Pleiotropic Effects of Anti-FXa Direct Oral Anticoagulants? - Styliani Papadaki, Alexandros D. Tselepis, 2019](https://journals.sagepub.com/cms/10.1177/0003319719840861/asset/images/large/10.1177_0003319719840861-fig1.jpeg)
Nonhemostatic Activities of Factor Xa: Are There Pleiotropic Effects of Anti-FXa Direct Oral Anticoagulants? - Styliani Papadaki, Alexandros D. Tselepis, 2019
![Biomedicines | Free Full-Text | Pharmacotherapy in COVID 19: Potential Impact of Targeting the Complement System Biomedicines | Free Full-Text | Pharmacotherapy in COVID 19: Potential Impact of Targeting the Complement System](https://www.mdpi.com/biomedicines/biomedicines-09-00011/article_deploy/html/images/biomedicines-09-00011-g002.png)